Due to significant developments in the pharmaceutical marketplace, new therapeutic strategies can be found. However, the lack of knowledge of the molecular mechanisms governing the fate of antibodies causes a obstacle as a way to find a curative treatment. The simplest therapeutic solution demands early prognosis and an optimum nonpharmacological https://www.directivepublications.org/journal-of-arthritis-and-rheumatology/